Latest in Cardiology from ACC.org

• Top Posters at ACC Middle East 2025 Address High Non-HDL-C, RV Impairment, Flurpiridaz F 18 PET MPI
  As the ACC Middle East 2025 Together With 16th Emirates Cardiac Society Conference winds down in Dubai, UAE, the three winners of the conference's abstract competition were announced and invited to present at ACC.26 in New Orleans, LA.
• Dual Antiplatelet Therapy May Reduce Stroke Risk After Valve-in-Valve TAVI
  When compared with single antiplatelet therapy (SAPT), dual antiplatelet therapy (DAPT) after valve-in-valve TAVI to treat surgical bioprosthesis dysfunction may be associated with a lower one-year stroke incidence, according to a study presented at the 46th National Congress GISE 2025...
• ACC CardiaCast: PulseCheck: CV Care in Pregnancy: The Essentials
  In this episode, Andrea Price, MS, AACC hosts Andrea M. Russo, MD, FACC and Erin Ferranti, PhD, MPH, RN to introduce the field of cardio-obstetrics and its importance to listeners.
• LAAO in Patients With Prior Intracranial Hemorrhage, Ischemic Stroke Despite OAC, More
  Recent left atrial appendage occlusion (LAAO) research published in JACC: Clinical Electrophysiology and JACC: Advances explores outcomes in patients with prior intracranial hemorrhage (ICH) as well as those with prior ischemic stroke despite oral anticoagulation (OAC) and compares adjudicated registry-reported events with claims data. Two of these studies used data from ACC’s LAAO Registry.
• ACC CardiaCast: 2024 ACC Expert Consensus Decision Pathway for Treatment of HFrEF
  In this episode, Vanessa Blumer, MD, FACC, and Ersilia M. DeFilippis, MD, FACC, discuss the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction (HFrEF).